Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Boston Scientific Corporation, a leading name in the electromedical and electrotherapeutic apparatus manufacturing industry, is headquartered in the United States. Founded in 1979, the company has established itself as a pioneer in developing innovative medical devices that enhance patient care across various therapeutic areas, including cardiology, urology, and endoscopy.
With a strong presence in North America, Europe, and Asia, Boston Scientific is renowned for its cutting-edge products, such as stents, catheters, and neuromodulation devices. These offerings are distinguished by their advanced technology and commitment to improving patient outcomes. The company has achieved significant milestones, including numerous FDA approvals and recognitions for its contributions to healthcare innovation, solidifying its position as a trusted leader in the medical device sector.
+15 vs industry average
Boston Scientific’s score of 80 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Electromedical and Electrotherapeutic Apparatus Manufacturing has below-average carbon intensity
The Electromedical and Electrotherapeutic Apparatus Manufacturing industry has reduced its overall emissions by 28% since 2018
Scope 3 accounts for ••• of total emissions.
Boston Scientific's carbon emissions performance and climate commitments demonstrate a proactive approach to environmental stewardship within the electromedical and electrotherapeutic apparatus manufacturing industry.
Recent Emissions Data:
For the year 202
Access structured emission data, company specific factors and auditable source documents
2050
97% reduction in scope 3 total
Boston Scientific Corporation also commits to reduce scope 3 GHG emissions 97.0% per USD value added by 2050 from a 2024 base year.
2050
90% reduction in Scope 1
Boston Scientific Corporation commits to reduce absolute scope 1 GHG emissions 97.0% by 2050 from a 2019 base year.
2050
90% reduction in Scope 2
Boston Scientific Corporation commits to reduce absolute scope 2 GHG emissions 97.0% by 2050 from a 2019 base year.
See all 10 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


Common questions about Boston Scientific’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more